Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Terence Rooney currently holds 76,000 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Terence Rooney has been a net neutral trader of KYMR stock. They have purchased $0 and sold $0 worth of shares.
Terence Rooney's most recent insider trade was on Jul 27, 2026, when they sold 76,000 shares at $0.00 per share.
Terence Rooney serves as Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Terence Rooney holds the position of Chief Medical Officer at Kymera Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Terence Rooney has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Terence Rooney was on Jul 27, 2026, when they purchased $0 worth of KYMR shares. This transaction involved 76,000 shares at N/A per share.
Terence Rooney currently owns 76,000 shares of Kymera Therapeutics, Inc. (KYMR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Terence Rooney's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Terence Rooney has 2 Form 4 filings on record as an insider at Kymera Therapeutics, Inc..
Set alerts for Terence Rooney and 40,000+ other insiders.